Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Bajaj Healthcare’s stock has surged, fuelled by regulatory approvals and expansion into high-growth markets. But with a ...

In 2023, global cannabis sales were estimated at $32 billion, with North America dominating over 75% of total revenue due to widespread legalization in the U.S. and Canada. However, international ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

He leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments for people with epilepsy and related brain diseases ...

“The addition of these five esteemed scientists to our SAB reflects our deepening clinical focus on epilepsy ... These factors include the company’s financial position and operational runway ...

Charles Schwab Investment Management Inc. boosted its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report ...

MidCap Financial Investment (MFIC) came out with quarterly ... but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements ...

Investing in art can enhance your financial portfolio and offer personal satisfaction. However, it requires careful research, strategic planning, and expert guidance. By starting small ...

New seizure and driving guidelines emphasize medical boards for licensing decisions and give physicians more flexibility and ...

In addition to Probudur, the company is also working on Envelta for acute and chronic pain management and NobrXiol for rare pediatric epilepsy. Virpax has established cooperative research and ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...